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ABSTRACT
Leishmaniasis is a parasitic disease found in the continents of Europe, Asia, Africa and the Americas. 
In Brazil, the disease is an important public health problem, occurring in most states, but mainly in 
the Northeast region of the country, with the state of Alagoas having a signifi cant number of con-
fi rmed cases. 
The present study establishes and discusses the epidemiological profi le of cases of leishmaniases 
treated at the Reference Center of Alagoas, Hospital Escola Hélvio de Farias Auto, between January 
2000 and October 2008. During thisperiod, records of 2,104 patients notifi ed to the hospital Epide-
miological Surveillance Center were reviewed. The epidemiology of leishmaniasis, both visceral and 
tegumentary, has shown a profi le that has changed over throughout the years, with a decrease in the 
number of notifi ed cases. Disease occurrence was associated with lower social economic classes, and 
affected mainly rural workers in general, housewives and students.
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INTRODUCTION
Leishmaniasis is a disease caused by protozoan 
parasites of the Leishmania genus, transmitted to 
man by the bite of an insect of the Lutzomyia ge-
nus, known as sand-ﬂ y. The disease has different 
clinical forms, ranging from a skin ulcer, which 
can heal spontaneously, to the most severe form 
of leishmaniasis, the visceral form, which can lead 
to patient’s death when untreated (WHO, 1990). 
According to the location and species of the etio-
logic agent, leishmaniasis is classifi ed as Ameri-
can tegumentary leishmaniasis (ATL), or visceral 
leishmaniasis (VL), also known as Kala-azar. Sev-
eral forms of the disease have been reported in the 
continents of Europe, Asia, Africa and the Ameri-
cas. Due to its frequency and lethality, mainly in 
untreated patients, it is currently among the six 
endemic diseases considered as priorities world-
wide (WHO, 1990; BRASIL, 2003). Brazil is 
among the fi ve countries with the largest number 
of cases of leishmaniasis, which represents an 
important public health problem, especially in 
the North, Midwest and Northeast regions of the 
country (COSTA, 2005). In recent years, an in-
crease in the number of this parasitic disease has 
been observed in residential or peri-residential 
areas, especially in the Northeast region, where 
socioeconomic factors – such as housing condi-
tions, poverty, migration process and lack of basic 
sanitation – favor the spread of disease expansion 
(Brasil, 2003; Costa, 2005; Lainson, 1978).
In Brazil, the number of cases has been in-
creasing, both in magnitude and geographic ex-
pansion. Two distinct epidemiological profi les can 
be observed, expressed as the maintenance of cases 
that originated from old sources and surrounding 
areas, or by the onset of outbreaks associated with 
factors such as the accelerated expansion process 
of agricultural frontiers, the implementation of 
prospecting areas, road constructions and inva-
sion of the city-outskirt areas, among several oth-
ers. From 1985 to 1999, a total of 388,155 autoch-
thonous cases of ATL were notifi ed in the country. 
In this time period, the coeffi cient of ATL detec-
tion in Brazil has increased from 10.45/100,000 
inhabitants to 18.63/100,000 inhabitants, prob-
ably as a result of an improvement in disease noti-
fi cation in the country (BRASIL, 2000). 
According to the Department of Informatics of 
the Brazilian Public Health System (SUS), DATA-
SUS, a total of 33,872 cases of ATL per year were 
notifi ed in Brazil from 1999 to 2003. The disease 
has been reported in all states, and has spread to 
new geographic areas, with 169,361 cases notifi ed 
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in the period. The Southern region reported the lowest number 
of cases (3,952), whereas the Northern region had the highest 
burden of cases (61,339) during the described period, with in-
cidence rates per 100,000 inhabitants between 114.8 and 163.5. 
In the Amazon region, 12,005 cases have been notifi ed in the 
same period, with mean incidence rates of 86.77; in the year 
2003, the incidence rate reached 121.03, when 3,174 cases were 
reported, 60.18% occuring in the city of Manaus, state of Ama-
zonas, Brazil (BRASIL, 2005).
According to the Ministry of Health, throughout 19 years 
of notifi cation, the number of VL cases totaled 48,455, with 
approximately 66% of them occurring in the states of Bahia, 
Ceará, Maranhão and Piauí. In the last ten years, the mean 
annual number of cases in the country was 3,156, and the in-
cidence was of 2/100,000 inhabitants. The disease is more fre-
quent among children < 10 years (54.4%), with 41% of the cas-
es being recorded in children < 5 years. Men is proportionally 
more affected (60%). 
By having access to reliable data on this matter, the govern-
mental institutions are aware that leishmaniasis is an important 
public health problem in our country and can prioritize disease 
prevention and control measures. 
The present article describes the epidemiological profi le 
of leishmaniasis cases treated in the state of Alagoas, tak-
ing into account a high prevalence between 2000 and 2002, 
followed by a decrease between 2003 and 2008, as demon-
strated in Charts 1 and 2. 
MATERIAL AND METHODS
The present study was a retrospective review of medical 
records of 2,104 cases diagnosed with VL or ATL notifi ed 
to the Epidemiological Surveillance Center of the University 
Hospital Dr. Hélvio de Farias Auto (HEHA), in the city of 
Maceió, state of Alagoas, Brazil, from January 2000 to Oc-
tober 2008. 
The following patient variables were analyzed: age, sex, 
city of residence, occupation, clinical manifestations, diag-
nosis, administered drugs and case outcome. 
Data were tabulated and analyzed through descriptive 
statistics in a Microsoft Excel spreadsheet, release 2003. The 
study was approved by the Research Ethics Committee of 
Universidade Estadual de Ciências da Saúde de Alagoas – 
CEP/UNCISAL, process # 1007.
 
RESULTS
During the period of January 2000 to October 2008, a to-
tal of 2,104 cases of leishmaniasis were diagnosed, of which 
1,293 were ATL and 811 were VL. 
The highest concentration (23.7%) of reported cases was 
at the capital city Maceió (n = 302), followed by 11.2% in 
the city of Joaquim Gomes (n = 142), 5.5% at União dos 
Palmares (n = 70), and 4.4% at Chã Preta (n = 56). Fifty-
fi ve cities/towns did not report any case of ATL. Regarding 
VL, the city with the highest number of reported cases was 
Santana do Ipanema (n = 59) with 7.9%, followed by 5.6% 
at Palmeira dos Indios (n = 42), 5.5% at Traipu (n = 41), 
and 5.5% at São José da Tapera (n = 41). Twenty-three cities/
towns did not report any case of VL. 
In the period of 2000 to 2002 the highest number of cas-
es was reported, with 546 cases of VL and 804 cases of ATL, 
corresponding to 64% of the total period between 2000 and 
2008 (Table 1).
Table 1. Number of cases
Year VL ATL 
2000 230 378
2001 211 112
2002 105 314
2003 46 119
2004 56 175
2005 54 70
2006 45 49
2007 25 26
2008 31 46
Total 811 1293  
Source: Epidemiological Surveillance Center of the University 
Hospital Hélvio Auto
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Chart 1: Cases of visceral leishmaniasis notified annually.
Source: Epidemiological Surveillance Center of Hospital Escola Hélvio Auto
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Chart 2: Cases of tegumentary leishmaniasis notified 
annually.
Source: Epidemiological Surveillance Center of Hospital Escola Hélvio Auto
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Sixty-three percent were male among the 823 cases with 
ATL, and 58.8% among the 477 VL cases.
The majority of the ALT cases were in the age ranges of 
cases 0-12 (19,8%) and 19-45 years (42.4%); among LV cases, 
67.4% and 13.5% were in the age ranges of 0-12 and 19-30 
years, respectively. There were only 6.8% of the leishmaniasis 
cases reported in patients over 61 years old. 
Regarding occupation, students had the highest rate of ATL 
infection, with 25.8% (n = 145), followed by housewives with 
29.2% (n = 164); as for VL, rural workers had the highest rate, 
with 6.2% (n = 51), followed by students, with 5.4% (n = 44).
All cases presented a clinical picture indicative of the dis-
ease. Most ATL cases presented skin lesions as the only manifes-
tation of the disease (Table 2). Among VL cases, symptoms such 
as fever (n = 673), splenomegaly (n = 681) and hepatomegaly 
(n=637) were the most clinical features (Tables 2 and 3).
Indirect immunoﬂ uorescence assay (IFA) turned out posi-
tive in 37.1% (n = 301), whereas parasitological tests were posi-
tive in 47.1% (n = 382) Among ATL cases, the Montenegro skin 
test (MST) had a positive result more often 56.1% than the 
parasitological tests (9.3%). The low percentage of the parasito-
logical tests for the diagnosis of ATL resulted in a high number 
of patients that were not submitted to the method.
Ninety-fi ve percent of both ATL and VL patients were treat-
ed primarily with pentavalent antimony (n = 1757), whereas 
Amphotericin b (n = 91) was used by 4.9%. The remaining 
0.1% received other drugs, such as pentamidine and liposomal 
Amphotericin b. 
Of the 1,293 cases of ATL, 576 were reassessed and dis-
charged due to clinical cure, 21 abandoned treatment, 30 died 
due to ATL, and 99 died due to other causes. 
Of the 811 cases of VL, 379 were reassessed and discharged 
due to clinical cure, 80 died due to LV and 271 were referred to 
another service.
Table 2. Clinical presentation of ATL cases
Lesion Total % 
Skin 683 52.8 
Mucosa 94 7.2 
Source: Epidemiological Surveillance Center of Hospital 
Escola Hélvio Auto
Table 3. Clinical symptoms among VL cases
Symptoms Number %
Fever 675 83.3
Weakness 312 38.51
Weight loss 259 31.9
Coughing 235 26.9
Splenomegaly 681 84
Hepatomegaly 637 89.8
Source: Epidemiological Surveillance Center of Hospital 
Escola Hélvio Auto
DISCUSSION
The number of cases of leishmaniasis in Brazil continue 
to increase, despite the actual incidence of the disease be 
probably underestimated, as the disease spread to new 
geographic areas, (Brasil, 2003; Brasil, 2007). 
There has been a remarkable decrease in the number 
of notified cases for the state of Alagoas, Brazil, in the last 
four years, which contradicts the growth trend in Brazil, 
although the number of cases is still elevated. 
The cities/towns in the state of Alagoas with the high-
est incidence of ATL cases were Maceió, Joaquim Gomes, 
União dos Palmares, and Chã Preta. The disease outbreak 
in the capital city, Maceió, might have been associated to 
the urban expansion as a result of deforestation and pres-
ervation of small circumscribed areas of residual forest, 
ciliary forest and those resulting from reforesting (Corte 
AA, 1996). The cities/towns with the highest incidence of 
VL cases were Santana do Ipanema, Palmeira dos Indios, 
Traipu and São José da Tapera. In this case, there was a 
more homogenous distribution of cases. 
Women, children, urban-area dwellers and individu-
als whose occupations do not necessarily require entering 
the wooded areas more frequently to acquire the disease 
suggest this possibility, as proposed by other studies (Fol-
lador, 1999; Nunes, 2006; Guerra, 2006). The reason for 
the higher susceptibility presented by children could be 
explained by the state of relative immaturity of cellular 
immunity, aggravated by malnutrition, which is very 
common in the endemic areas, in addition to a higher lev-
el of exposure to the disease vector in the peri-residential 
areas. The present study showed a male predominance 
among cases, differently from what has been reported 
elsewhere. Occupations, such as students and housewives 
were disproportionately represented among cases, as they 
tend to have close contact to domestic animals, typical 
hosts of the disease. 
Practically all cases presented typical signs of the 
disease, with fever, splenomegaly and hepatomegaly be-
ing the most frequently reported clinical findings in VL. 
Splenomegaly, which in some series was present in all pa-
tients, was observed in 83.9% of the cases in the present 
study, in accordance to other authors who reported 
splenomegaly in 2 to 18% of the cases (Cascio A, 2002; 
Cole ACE, 1944). The predominance in exposed areas of 
the body and the ulcerated aspect correspond to the most 
frequent description of the skin lesions in ATL (Chiari 
CA, 1973). In the present study, the cutaneous form was 
most frequently observed in ATL. 
The diagnosis of ATL, both cutaneous and mucosal 
forms, is eminently clinical, supplemented by subsidi-
ary laboratory tests, such as direct analysis of material 
scraped or aspirated from the lesion, stained by Giemsa’s 
or Leishman’s stain, histopathological examination (HE) 
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of lesion biopsy, the Montenegro skin test (MST) and the 
indirect immunofluorescence assay (IFA) (Davies CR, 
2003; Silveira FT, 2004). The most frequently used meth-
ods in ATL were IFA followed by the parasitological test. 
In VL, IFA and the parasitological test were used more 
often, contributing equally to the diagnosis. 
The N-methyl-glucamine antimoniate (Glucantime®) 
is the only pentavalent formulation commercialized in 
Brazil. It is presented in 5-mL ampoules containing 1.5 g 
of raw antimoniate, equivalent to 425 mg of Sb5+; there-
fore, each mL contains 85 mg of Sb5+ (FUNASA, 2000). 
Other drugs, such as sulphas, ketoconazole, allopurinol, 
aminosidine and Amphotericin B are alternative thera-
pies. In addition to patient adherence, treatment success 
depends on the time elapsed from diagnosis to initiation 
of therapy (Passos, 2000). The present study pentavalent 
antimony was the treatment of choice for both ATL and 
VL, followed by Amphotericin B in a minority of pa-
tients. 
In the present study the cure rate was less than 50% for 
the two clinical forms of leishmaniasis. Additionally, there 
was no information regarding patient outcome available 
in the medical records. Death due to leishmaniasis could 
be explained by delayed initiation of therapy. 
CONCLUSION
Leishmaniasis is a disease that has accompanied mankind 
since ancient times. There has been an increase in the 
number of cases in the last 20 years, as well as expansion 
new geographic areas. 
Currently, the disease is an important public health 
problem and represents a challenge for health profession-
als. Epidemiological studies might help planning for ef-
fective strategies to control VL and ATL. To this end, a 
better control of the canine population and surveillance 
strategies must be intensified. 
The scarcity of investments in public health in the 
country, especially in preventive measures, aggravated 
by the fact that Brazil is located in a tropical region, of 
which climate is favorable to the development of several 
endemic diseases, contribute to maintain leishmaniasis as 
an important public health problem in the country. 
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